Random 3 Flashcards
(17 cards)
Catecholamine degradation
Enzymatic degradation occurs via catechol-O-methyltransferase (COMT) and monoamine oxidase (MAO).
MAO can be blocked by MAO inhibitors to elevate catecholamine concentration in synaptic cleft.
3,4-Dihydroxyphenylacetic acid (DOPAC) is a neuronal metabolite formed by the breakdown of dopamine by monoamine oxidase.
Vanillylmandelic acid (VMA) is an end-stage metabolite. Urinary excretion is elevated in patients with pheochromocytoma and neuroblastoma.
Phenylketonuria
A congenital disorder characterized by the accumulation of phenylalanine in the central nervous system.
Can be caused by a defect of phenylalanine hydroxylase (classic PKU) or deficiency in tetrahydrobiopterin (malignant PKU).
Causes psychomotor retardation, seizures, a musty odor, and pale skin/hair (from lack of melanin production).
Cushing disease
Patient with signs of Cushing syndrome: weight gain with central obesity, abdominal striae, hypertension, hyperpigmentation, and irregular menses. A positive low-dose dexamethasone suppression test indicates hypercortisolism.
A serum ACTH within the reference range in this context is considered abnormal, as ACTH secretion should physiologically be suppressed by elevated serum cortisol levels.
Suppression of ACTH with high-dose dexamethasone confirms increased ACTH production from the pituitary gland (Cushing disease).
Chromaffin cells
Neuroendocrine cells that originate from the neural crest and migrate to the paraganglia and adrenal medulla during embryonic development.
Zona glomerulosa
The response of the zona glomerulosa to angiotensin II is attenuated by low serum potassium or high serum sodium levels
Angiotensin-converting enzyme (ACE)
Bradykinin is degraded by angiotensin-converting enzyme (ACE), a component of the renin-angiotensin-aldosterone system (RAAS).
ACE is produced by cells of the pulmonary endothelium. Circulating bradykinin is therefore primarily metabolized in the pulmonary vasculature.
Hypoglycemia in diabetics
(Relative) overdose of insulin or a noninsulin drug is by far the most common cause of hypoglycemia.
Consider factitious disorder in patients with access to insulin and other diabetes medications (e.g., healthcare professionals), for whom there is no other obvious explanation for hypoglycemia.
Recurrent hypoglycemia → changes in the counterregulatory autonomic response (e.g., decreased epinephrine release) → lower glucose threshold needed to trigger symptoms → asymptomatic hypoglycemia
Beta blockers can mask signs of hypoglycemia
Hypoglycemia: Neurogenic/autonomic symptoms
ncreased sympathetic activity: tremor, pallor, anxiety, tachycardia, sweating, and palpitations
Increased parasympathetic activity: hunger, paresthesias, nausea, and vomiting
Hypoglycemia: Neuroglycopenic symptoms
Agitation, confusion
Seizure
Somnolence → obtundation → stupor → coma → death
Beta blockers can mask signs of hypoglycemia
Communicating hydrocephalus
Pathophysiology Clinical features Diagnosis
Communicating hydrocephalus
↑ CSF production
↓ CSF absorption
Typical findings of raised ICP
Headache, nausea, and vomiting
Papilledema
Abducens nerve palsy
Abnormal gait
Impaired consciousness
Cushing triad (irregular breathing, widening pulse pressure, bradycardia)
Ultrasonography (children ≤ 18 months of age)
MRI or CT (older children and adults)
Communicating hydrocephalus can also be a complication of subarachnoid hemorrhage.
Communicating hydrocephalus: All ventricles are dilated
Noncommunicating hydrocephalus
Obstructed passage of CSF from the ventricles to the subarachnoidal space
Noncommunicating hydrocephalus: Ventricles upstream of the obstruction are dilated
Normal pressure hydrocephalus (NPH)
↓ CSF absorption
Classic triad
Wet: urinary incontinence
Wacky: dementia
Wobbly: frequent falls, broad-based gait with short, shuffling steps (gait apraxia)
MRI (initial test)
CSF tap test
Normal pressure hydrocephalus does not manifest with signs of increased ICP (e.g., headache, papilledema)
NPH is diagnosed based on typical clinical features, evidence of communicating hydrocephalus on imaging, and normal or only mildly elevated opening pressure
Patients can develop a flat affect due to disruption of frontal lobe circuits, particularly the dorsolateral prefrontal cortex and its connections.
Hydrocephalus ex vacuo
Loss of brain tissue
Symptoms of the underlying condition (e.g., Alzheimer disease, Pick disease)
Cortical atrophy may be prominent on imaging.
Cushing reflex
A hypothalamic response to maintain cerebral perfusion in patients with elevated ICP.
Results in the Cushing triad, which consists of increased systolic blood pressure, bradycardia, and irregular breathing
Tension headache
Photophobia/phonophobia (may occur)
No nausea, no vomiting
Autonomic symptoms are absent (lacrimation, rhinorrhea, sweating)
Chronic hydrocephalus
Signs of upper motor neuron damage (e.g., spasticity, hyperreflexia) are common in advanced, chronic hydrocephalus due to stretching of the motor cortices and pyramidal tracts around the dilated ventricles.
The lower extremities are typically affected because the cortical regions responsible for processing the motor functions of the lower extremities are located in the medial precentral gyrus (according to the motor homunculus), which is the most stretched part of the primary motor cortex in patients with hydrocephalus.